MOTS-c Functionally Prevents Metabolic Disorders
Metabolites · 13.01.2023 · 13 (1) · 125
DOI: 10.3390/metabo13010125 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 13.01.2023. Verfasst von Yue Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Laboratory Science, Guilin Medical University, Guilin 541004, China. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Science and Technology Base and Talent Project, National Natural Science Foundation of China, Guangxi Natural Science Foundation.
Abstract (Originalsprache)
Mitochondrial-derived peptides are a family of peptides encoded by short open reading frames in the mitochondrial genome, which have regulatory effects on mitochondrial functions, gene expression, and metabolic homeostasis of the body. As a new member of the mitochondrial-derived peptide family, mitochondrial open reading frame of the 12S rRNA-c (MOTS-c) is regarding a peptide hormone that could reduce insulin resistance, prevent obesity, improve muscle function, promote bone metabolism, enhance immune regulation, and postpone aging. MOTS-c plays these physiological functions mainly through activating the AICAR-AMPK signaling pathways by disrupting the folate-methionine cycle in cells. Recent studies have shown that the above hormonal effect can be achieved through MOTS-c regulating the expression of genes such as GLUT4, STAT3, and IL-10. However, there is a lack of articles summarizing the genes and pathways involved in the physiological activity of MOTS-c. This article aims to summarize and interpret the interesting and updated findings of MOTS-c-associated genes and pathways involved in pathological metabolic processes. Finally, it is expected to develop novel diagnostic markers and treatment approaches with MOTS-c to prevent and treat metabolic disorders in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medical Laboratory Science, Guilin Medical University, Guilin 541004, China.
- Department of Laboratory Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin 541199, China.
- Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical University, Guilin 541199, China.
- Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, Guilin 541199, China.
Förderung
- Guangxi Science and Technology Base and Talent Project
- National Natural Science Foundation of China
- Guangxi Natural Science Foundation
- Appropriate Health Technology Promotion Project of Guangxi Health Commission
Zitieren
APA
Gao, Y., Wei, X., Wei, P., Lu, H., Zhong, L., Tan, J., Liu, H., & Liu, Z. (2023). MOTS-c Functionally Prevents Metabolic Disorders. Metabolites, 13(1), 125. https://doi.org/10.3390/metabo13010125
Vancouver
Gao Y, Wei X, Wei P, Lu H, Zhong L, Tan J, et al. MOTS-c Functionally Prevents Metabolic Disorders. Metabolites. 2023;13(1):125. doi:10.3390/metabo13010125
BibTeX
@article{Gao2023,
author = {Gao, Yue and Wei, Xinran and Wei, Pingying and Lu, Huijie and Zhong, Luying and Tan, Jie and Liu, Hongbo and Liu, Zheng},
title = {MOTS-c Functionally Prevents Metabolic Disorders},
journal = {Metabolites},
year = {2023},
volume = {13},
number = {1},
pages = {125},
doi = {10.3390/metabo13010125}
}
EUVIMED